Skip to main content
. 2020 Jul 25;23(8):101411. doi: 10.1016/j.isci.2020.101411

Figure 1.

Figure 1

Establishment of Patient-Derived LADC Organoids

(A) Overview of experimental design.

(B) Expansion potential of LADC organoids established. Arrow, continuous expansion. Dot, passage.

(C) Representative H&E staining of LADC tissues together with the bright-field images and H&E staining of the organoids derived from corresponding tumor tissues. Early passage (passage 5–10) and late passage (>10). Scale bar, 100 μm.

See also Figure S2, Tables S1 and S2.